DC Field | Value | Language |
---|---|---|
dc.contributor.author | B M Kim | - |
dc.contributor.author | Y Hong | - |
dc.contributor.author | S Lee | - |
dc.contributor.author | P Liu | - |
dc.contributor.author | J H Lim | - |
dc.contributor.author | Y H Lee | - |
dc.contributor.author | T H Lee | - |
dc.contributor.author | Kyu Tae Chang | - |
dc.contributor.author | Y Hong | - |
dc.date.accessioned | 2017-04-19T10:14:21Z | - |
dc.date.available | 2017-04-19T10:14:21Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1422-0067 | - |
dc.identifier.uri | 10.3390/ijms161125991 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/12980 | - |
dc.description.abstract | Ionizing radiation (IR), such as X-rays and gamma (γ)-rays, mediates various forms of cancer cell death such as apoptosis, necrosis, autophagy, mitotic catastrophe, and senescence. Among them, apoptosis and mitotic catastrophe are the main mechanisms of IR action. DNA damage and genomic instability contribute to IR-induced cancer cell death. Although IR therapy may be curative in a number of cancer types, the resistance of cancer cells to radiation remains a major therapeutic problem. In this review, we describe the morphological and molecular aspects of various IR-induced types of cell death. We also discuss cytogenetic variations representative of IR-induced DNA damage and genomic instability. Most importantly, we focus on several pathways and their associated marker proteins responsible for cancer resistance and its therapeutic implications in terms of cancer cell death of various types and characteristics. Finally, we propose radiation-sensitization strategies, such as the modification of fractionation, inflammation, and hypoxia and the combined treatment, that can counteract the resistance of tumors to IR. | - |
dc.publisher | MDPI | - |
dc.title | Therapeutic implications for overcoming radiation resistance in cancer therapy | - |
dc.title.alternative | Therapeutic implications for overcoming radiation resistance in cancer therapy | - |
dc.type | Article | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.number | 11 | - |
dc.citation.endPage | 26913 | - |
dc.citation.startPage | 26880 | - |
dc.citation.volume | 16 | - |
dc.contributor.affiliatedAuthor | Kyu Tae Chang | - |
dc.contributor.alternativeName | 김병모 | - |
dc.contributor.alternativeName | 홍윤경 | - |
dc.contributor.alternativeName | 이승훈 | - |
dc.contributor.alternativeName | Liu | - |
dc.contributor.alternativeName | 임지홍 | - |
dc.contributor.alternativeName | 이용헌 | - |
dc.contributor.alternativeName | 이태호 | - |
dc.contributor.alternativeName | 장규태 | - |
dc.contributor.alternativeName | 홍용은 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, vol. 16, no. 11, pp. 26880-26913 | - |
dc.identifier.doi | 10.3390/ijms161125991 | - |
dc.subject.keyword | Cancer therapy | - |
dc.subject.keyword | Cell death | - |
dc.subject.keyword | DNA damage | - |
dc.subject.keyword | Ionizing radiation (IR) | - |
dc.subject.keyword | Prognostic markers | - |
dc.subject.keyword | Resistance | - |
dc.subject.keyword | Therapeutic targets | - |
dc.subject.local | cancer therapy | - |
dc.subject.local | Cancer therapy | - |
dc.subject.local | cell death | - |
dc.subject.local | Cell death | - |
dc.subject.local | DNA damage | - |
dc.subject.local | Ionizing radiation | - |
dc.subject.local | Ionizing radiation (IR) | - |
dc.subject.local | ionizing radiation | - |
dc.subject.local | Prognostic markers | - |
dc.subject.local | prognostic marker | - |
dc.subject.local | Prognostic marker | - |
dc.subject.local | Resistance | - |
dc.subject.local | resistance | - |
dc.subject.local | Therapeutic Targets | - |
dc.subject.local | therapeutic target | - |
dc.subject.local | therapeutic targets | - |
dc.subject.local | Therapeutic target | - |
dc.subject.local | Therapeutic targets | - |
dc.description.journalClass | Y | - |
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.